|
GB202019215D0
|
|
Treatment regimen
|
|
GB202017853D0
|
|
Treatment regimen
|
|
GB202014500D0
|
|
Treatment of hypothyroidism and related conditions
|
|
GB202001514D0
|
|
Treatment regimen
|
|
GB201913312D0
|
|
Treatment of hypothyroidism and related conditions
|
|
GB201815000D0
|
|
Treatment of hypothroidism and related conditions
|
|
GB201603752D0
|
|
Treatment of hypothyroidism
|
|
GB201603755D0
|
|
Treatment of hypothyroidism
|
|
HK1195491A1
|
|
Controlled drug release
|
|
AU2014200332A1
|
|
Lipid composition
|
|
GB201314372D0
|
|
Controlled drug release
|
|
GB201308933D0
|
|
Paediatric composition
|
|
GB201408444D0
|
|
Controlled drug release
|
|
GB201202433D0
|
|
Controlled drug release
|
|
GB201119985D0
|
|
Treatment of adrenal insufficiency
|
|
GB201102798D0
|
|
Treatment of adrenal insufficiency
|
|
GB201100650D0
|
|
Treatment of adrenal insufficiency
|
|
GB201100651D0
|
|
Treatment of inflammation
|
|
GB201017794D0
|
|
Multiparticulate formulation
|
|
GB0911867D0
|
|
Multiparticulate formulation
|
